沼液浸种对黑麦草种子发芽的影响

为了研究沼液浸种对黑麦草种子发芽的影响,设置4个浓度沼液分别浸泡黑麦草种子,分析种子各项发芽指标的变化。结果表明:各处理均能正常发芽,黑麦草种子的发芽率和发芽势等4项发芽指标均随着浸种沼液浓度的增加呈现先上升后下降的趋势,以75%沼液浓度浸种效果最优,但沼液浸种对发芽率和发芽势的影响要高于苗高和根长。综合分析认为利用沼液浸泡黑麦草种子是提高其生产性能的有力措施,适宜在生产中推广利用。     

控光增绒技术在辽宁绒山羊中应用效果观察

2010～2012年,辽宁省畜牧科学研究院先后在本院科技示范场、凤城市绒山羊养殖户,开展了辽宁绒山羊控光增绒试验,设置了不同控光时间的试验组以及相应的对照组,以期验证该项技术在辽宁地区和辽宁绒山羊生产中的应用效果。试验结果表明,该项技术对辽宁绒山羊增绒效果不明显,达不到一年两次剪绒、提高产绒量的目的,建议谨慎将该项技术应用于辽宁地区辽宁绒山羊生产中。     

棘孢木霉(Trichoderma asperellum)固态发酵产纤维素酶及酶的性质

<正>纤维素酶具有破坏植物细胞壁,促进营养物质的消化和吸收,消除抗营养因子,提高饲料营养价值等多种功能,因而成为饲料工业研究的热点。目前用于纤维素酶生产和研究的菌株多为霉菌。棘孢木霉是我国新记录的木霉种[1],目前国内尚未见该菌种产纤维素酶的文献报道。     

免疫抑制对苏拉灭和贝尼尔治疗小鼠伊氏锥虫病疗效的影响

用从自然感染宿主分离的伊氏锥虫原种ＪＧ的克隆ＪＧｍｃ１和ＪＧｍｃ５感染免疫活性正常小鼠和免疫抑制小鼠，２４ｈ后，以苏拉灭或贝尼尔治疗，两种药物对免疫抑制小鼠的ＣＤ１００均明显高于免疫活性正常小鼠，由经受一次苏拉灭或贝尼尔治疗未愈的免疫抑制小鼠分离的锥虫，感染免疫活性正常小鼠，再用原来对该克隆感染的免疫活性正常小鼠ＣＤ１００的苏拉灭或贝尼尔治疗即无效。用免疫溶解试验分别测定一组免疫抑制和免疫活性正确     

Spatiotemporal heterogeneity of PPARγ expression in porcine uteroplacenta for regulating of placental angiogenesis through VEGF-mediated signalling

Non-infectious prenatal mortality severely affects the porcine industry, with pathological placentation as a likely key reason. Previous studies have demonstrated that peroxisome proliferator-activated receptor gamma (PPARγ) deficiency causes defects in the uteroplacental vasculature and induces embryonic losses in mice. However, its role in porcine placental angiogenesis remains unclear. In the present study, PPARγ expression was investigated in porcine uteroplacental tissues at gestational day (GD) 25, GD40 and GD70 via quantitative polymerase chain reaction (qPCR), Western blot and immunohistochemistry (IHC). Moreover, the roles of PPARγ in porcine placental angiogenesis were investigated using a cell model of porcine umbilical vein endothelial cells (PUVECs) to conduct proliferation, migration and tube formation assays in vitro and a mouse xenograft model to assess capillary formation in vivo. The results showed that PPARγ was mainly located in the glandular epithelium, trophoblast, amniotic chorion epithelium and vascular endothelium, as indicated by the higher expression levels at GD25 and GD40 than at GD70 in endometrium and by higher expression levels at GD40 and GD70 than at GD25 in placenta. Moreover, PPARγ expression was significantly downregulated in placenta with dead foetus. In PUVECs, knocking out PPARγ significantly inhibited proliferation, migration and tube formation in vitro and inhibited capillary formation in mouse xenografts in vivo by blocking S-phase, promoting apoptosis and downregulating the angiogenic factors of VEGF and its receptors. Overall, the spatiotemporal heterogeneity of PPARγ expression in porcine uteroplacental tissue suggests its vital role in endometrial remodelling and placental angiogenesis, and PPARγ regulates placental angiogenesis through VEGF-mediated signalling.     

Pharmacokinetics and bioavailability of valnemulin in broiler chickens

Wang, R., Yuan, L.G., He, L.M., Zhu, L.X., Luo, X.Y., Zhang, C.Y., Yu, J.J., Fang, B.H., Liu, Y.H. Pharmacokinetics and bioavailability of valnemulin in broiler chickens. J. vet. Pharmacol. Therap. 34 , 247–251. The objective of this study was to investigate the pharmacokinetics and bioavailability of valnemulin in broiler chickens after intravenous (i.v.), intramuscular (i.m.) and oral administrations of 10 mg/kg body weight (bw). Plasma samples were analyzed by high‐performance liquid chromatography–tandem mass spectrometry (HPLC‐MS/MS). Pharmacokinetic characterization was performed by non‐compartmental analysis using WinNonlin program. After intravenous administration, distribution was wide with the volume of distribution based on terminal phase(V_z) of 4.27 ± 0.99 L /kg. Mean valnemulin t_1/2β(h), Cl_β(L /h /kg), V_ss (L /kg) and AUC_(0–∞)(μg·h /mL) values were 2.85, 0.99, 2.72 and 10.34, respectively. After intramuscular administration, valnemulin was rapidly absorbed with a C_max of 2.2 μg/mL achieved at 0.43 h (t_max), and the absolute bioavailability (F) was 88.81%; and for the oral route the same parameters were 0.66 ± 0.15 μg/mL, 1.54 ± 0.27 h and 74.42%. A multiple‐peak phenomenon was present after oral administration. The plasma profile of valnemulin exhibited a secondary peak during 2–6 h and a tertiary peak at 32 h. The favorable PK behavior, such as the wide distribution, slow elimination and acceptable bioavailability indicated that it is likely to be effective in chickens.